Cargando…
Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting
Major immunotherapy challenges include a limited number of predictive biomarkers and the unusual imaging features post-therapy, such as pseudo-progression, which denote immune infiltrate-mediated tumor enlargement. Such phenomena confound clinical decision-making, since the cancer may eventually reg...
Autores principales: | Kato, Shumei, Li, Bing, Adashek, Jacob J., Cha, Seong Won, Bianchi-Frias, Daniella, Qian, Dajun, Kim, Lisa, so, Tiffany W, Mitchell, Marcus, Kamei, Naoki, Hoiness, Robert, Hoo, Jayne, Gray, Phillip N., Iyama, Teruaki, Kashiwagi, Masahide, Lu, Hsiao-Mei, Kurzrock, Razelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966985/ https://www.ncbi.nlm.nih.gov/pubmed/35371621 http://dx.doi.org/10.1080/2162402X.2022.2052410 |
Ejemplares similares
-
High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting
por: Joshi, Rushikesh S., et al.
Publicado: (2022) -
The paradox of cancer genes in non-malignant conditions: implications for precision medicine
por: Adashek, Jacob J., et al.
Publicado: (2020) -
Comprehensive Analysis of Human Epidermal Growth Factor Receptor 2 Through DNA, mRNA, and Protein in Diverse Malignancies
por: Shayeb, Akram Mesleh, et al.
Publicado: (2023) -
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
por: Adashek, Jacob J., et al.
Publicado: (2019) -
Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer
por: Adashek, Jacob J., et al.
Publicado: (2020)